Differential changes in QTc duration during in-hospital haloperidol use

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Haloperidol is an antipsychotic medication with known effects on cardiac repolarization.
• QT interval prolongation is a risk factor for potentially fatal arrhythmias like Torsades de Pointes.
• Understanding haloperidol's impact on QT duration is crucial for patient safety.

Purpose of the Study:

• To assess changes in QT duration during low-dose haloperidol administration.
• To identify clinical factors associated with dangerous QT prolongation.
• To inform safe prescribing practices for haloperidol.

Main Methods:

• Retrospective cohort study of 1788 patients receiving haloperidol.
• Measurement of rate-corrected QT duration (QTc) before, during, and after haloperidol use.
• Logistic regression analysis to determine risk factors for QT prolongation.

Main Results:

• Patients with normal baseline QTc showed a significant QTc increase of 23 ms during haloperidol use.
• Twenty-three percent of patients with normal baseline QTc developed abnormal levels.
• Surgery before haloperidol use and shorter baseline QTc independently predicted dangerous QT prolongation.

Conclusions:

• Haloperidol alters QTc duration differently based on baseline QTc.
• Patients with normal baseline QTc are at risk for significant prolongation.
• Pre-haloperidol QTc duration and prior surgery are critical predictors of adverse QT events.